Arbutus Biopharma Corp. (ABUS)
5.18
+0.01
(+0.19%)
USD |
NASDAQ |
Aug 28, 09:51
Arbutus Biopharma EPS Diluted (TTM) : 0.7834 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7834 |
| March 31, 2026 | 0.8225 |
| December 31, 2025 | -0.1754 |
| September 30, 2025 | -0.2219 |
| June 30, 2025 | -0.2858 |
| March 31, 2025 | -0.4042 |
| December 31, 2024 | -0.3774 |
| September 30, 2024 | -0.4261 |
| June 30, 2024 | -0.4418 |
| March 31, 2024 | -0.4394 |
| December 31, 2023 | -0.4387 |
| September 30, 2023 | -0.466 |
| June 30, 2023 | -0.4623 |
| March 31, 2023 | -0.4548 |
| December 31, 2022 | -0.4599 |
| September 30, 2022 | -0.4689 |
| June 30, 2022 | -0.592 |
| March 31, 2022 | -0.7304 |
| December 31, 2021 | -0.8339 |
| September 30, 2021 | -0.9133 |
| June 30, 2021 | -0.9479 |
| March 31, 2021 | -0.9595 |
| December 31, 2020 | -0.9986 |
| September 30, 2020 | -1.228 |
| June 30, 2020 | -2.455 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.668 |
| December 31, 2019 | -2.885 |
| September 30, 2019 | -2.802 |
| June 30, 2019 | -1.789 |
| March 31, 2019 | -1.320 |
| December 31, 2018 | -1.214 |
| September 30, 2018 | -1.508 |
| June 30, 2018 | -1.23 |
| March 31, 2018 | -1.57 |
| December 31, 2017 | -1.55 |
| September 30, 2017 | -4.868 |
| June 30, 2017 | -5.028 |
| March 31, 2017 | -7.168 |
| December 31, 2016 | -7.138 |
| September 30, 2016 | -3.25 |
| June 30, 2016 | -3.45 |
| March 31, 2016 | -1.25 |
| December 31, 2015 | -1.34 |
| September 30, 2015 | -1.51 |
| June 30, 2015 | -1.33 |
| March 31, 2015 | -1.34 |
| December 31, 2014 | -1.85 |
| September 30, 2014 | -1.73 |
| June 30, 2014 | -1.744 |
| March 31, 2014 | -1.679 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Moderna, Inc. | -7.985 |
| Insmed, Inc. | -4.105 |
| Pfizer Inc. | 0.7552 |
| Gossamer Bio, Inc. | -0.6959 |
| Legend Biotech Corp. | -0.5051 |